Alector (ALEC) EBT Margin Growth (1y) (2019 - 2026)
Powered by 
Analysis
Alector (ALEC) EBT Margin Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 1,045.00 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -16,571.00 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | -153.00 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | -571.00 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 553.00 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 4,709.00 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1,911.00 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -2,328.00 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 29,565.00 |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -30,090.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30,090.00 |
| Mar 31, 2026 | -109,061.00 |
| Dec 31, 2025 | -59,109.00 |
| Sep 30, 2025 | -78,821.00 |
| Jun 30, 2025 | -13,172.00 |
| Mar 31, 2025 | -87,458.00 |
| Dec 31, 2024 | 25,807.00 |
| Sep 30, 2024 | 19,932.00 |
| Jun 30, 2024 | -26,086.00 |
| Mar 31, 2024 | 4,469.00 |
| Dec 31, 2023 | 9,628.00 |
| Sep 30, 2023 | -16,872.00 |
| Jun 30, 2023 | -876.00 |
| Mar 31, 2023 | -9,245.00 |
| Dec 31, 2022 | 3,929.00 |
| Sep 30, 2022 | -37,519.00 |
| Jun 30, 2022 | 85,331.00 |
| Mar 31, 2022 | 109,016.00 |
| Dec 31, 2021 | 68,975.00 |
| Sep 30, 2021 | 97,978.00 |